Viatris (VTRS)
(Delayed Data from NSDQ)
$11.34 USD
+0.17 (1.52%)
Updated Sep 11, 2024 03:59 PM ET
After-Market: $11.34 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth D Momentum C VGM
Earnings News For VTRS
-
Viatris (VTRS) Q2 Earnings Outpace Estimates, Sales Miss
-
Viatris (VTRS) Q2 Earnings Surpass Estimates
-
Viatris: Q2 Earnings Snapshot
-
Viatris Reports Second Quarter Financial Results for 2024
-
Earnings Preview: Viatris (VTRS) Q2 Earnings Expected to Decline
-
Viatris (VTRS) to Report Q2 Earnings: What's in the Cards?
-
Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down
-
Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates
-
Viatris: Q1 Earnings Snapshot
-
Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges
-
Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?
-
Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?
-
Why Is Viatris (VTRS) Down 3.5% Since Last Earnings Report?
-
Viatris' (VTRS) Generic Declines in Q4, Yupleri Sales Rise
-
Viatris' (VTRS) Q4 Earnings and Revenues Miss Estimates
-
Viatris: Q4 Earnings Snapshot
-
Viatris: Q4 Earnings Snapshot
-
Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
-
Viatris (VTRS) to Report Q4 Earnings: Is a Beat in Store?
-
Viatris (VTRS) Up 5.1% Since Last Earnings Report: Can It Continue?
-
Viatris (VTRS) Q3 Earnings Beat, Complex Generics Sales Dip
-
Viatris: Q3 Earnings Snapshot
-
Viatris (VTRS) Beats Q3 Earnings Estimates
-
Viatris Reports Strong Financial and Operational Results for the Third Quarter 2023 and Reaffirms Full-Year 2023 Adjusted EBITDA and Free Cash Flow Guidance Ranges[1]
-
Viatris (VTRS) to Report Q3 Earnings: Is a Beat in Store?